Stock Market | FinancialContent Business Page
FinancialContent fully hosted finance channel
Source: financialcontent.com
📰 Dose Level News
Page 2 - Dose Level News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dose Level. Real-time updates on events, politics, business and more.
Precigen Announces Positive Phase 1 Data for PRGN-3005 Autologous UltraCAR-T® Cells Manufactured Overnight for Infusion Next Day to Advanced Stage Platinum Resistant Ovarian Cancer Patients
– PRGN-3005 was well-tolerated with no dose limiting toxicities, no CRS greater than Grade 2, and no neurotoxicity – – PRGN-3005 cells demonstrated expansion...
Source: prnewswire.com
Precision BioSciences Provides Update on Allogeneic CAR T Programs and Regulatory Path Forward
Azer-Cel Safety Profile was Significantly Improved Compared to Prior Cohorts in Patients Dosed Using Optimized Product at Lower Intensity Lymphodepletion; No Grade 3 or Greater Allogeneic CAR T... | May 31, 2023
Michael Amoroso Precision Biosciences Inc Drug Administration Precision Biosciences Chief Executive Officer Potential First In Class Allogeneic
Source: marketscreener.com
Precigen Reports First Quarter 2023 Financial Results and Business Updates
– Positive Phase 1 clinical data presented for PRGN-2012 AdenoVerse™ immunotherapy in RRP demonstrated favorable safety profile and significant reduction in...
Source: prnewswire.com
Precision BioSciences Reports First Quarter 2023 Financial Results and Provides Business Update
- Program Updates Planned for Azer-cel and PBCAR19B in May 2023 - Presented data on PBGENE-HBV program at Global Hepatitis Summit 2023; PBGENE-DMD program data update upcoming at ASGCT... | May 9, 2023
United States Michael Amoroso Eli Lilly Los Angeles Trademark Office American Society Of Gene Cell Therapy Meeting
Source: marketscreener.com
Cellectis S A : PRELIMINARY NOTE - Form 6-K
PRELIMINARY NOTE The unaudited condensed Consolidated Financial Statements for the three-month period ended March 31, 2023, included herein, have been prepared in... | May 4, 2023
Source: marketscreener.com
Small Cap Stocks With Large Potential (CLSH,INAB,MGRX,GETY,IDYA)
Small Cap Stocks Are Back In Focus As major technology corporations such as Microsoft, Alphabet, Amazon, and Meta prepare to disclose their quarterly financial results, industry experts are closely... | April 25, 2023
United States Mangoceuticals Inc Holdings United States Inc Trillium Capital Getty Images Holding Inc Getty Images Holdings Inc
Source: marketscreener.com
IN8bio Stock More Than Doubles As Cancer Drug's Phase 1 Trial Reveals Positive Data
Shares of IN8bio, Inc. (INAB) surged nearly 120% on Monday morning after the company revealed positive, new INB-100 data showing long-term complete remissions and elevated gamma-delta T cells in 100% of evaluable treated leukemia patients.
Source: rttnews.com
MUSTANG BIO, INC. Management's Discussion and Analysis of the Results of Operations (form 10-K)
Statements in the following discussion and throughout this report that are not historical in nature are forward-looking statements. You can identify forward-looking statements by the use of words such... | March 30, 2023
Source: marketscreener.com
Precigen Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
– Achieved significant clinical progress for UltraCAR-T® and AdenoVerse™ investigational therapeutics in 2022 – – Presented positive clinical data for...
United States Mayo Clinic In Rochester Harry Thomasian Jr Precigen Ultra Stevenm Harasym Precigen Adenoverse
Source: prnewswire.com